CABIO Biotech (Wuhan) Co. Ltd.SSE: 688089

(688089)"Cabio Biotech (Wuhan) Co., Ltd."Report for Q3 2026

Oct 30, 2026 · Issued by CABIO Biotech (Wuhan) Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688089 · Oct 30, 2026

On 6ix: 6ix.com/news/688089cabio-biotech-wuhan-co-ltdreport-for-q3-2026

Report for Q3 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix is reading this filing.

View original source (Shanghai Stock Exchange)CABIO Biotech (Wuhan) Co. Ltd. on 6ix

Earlier from CABIO Biotech (Wuhan)

(688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Resignation of the Securities Affairs RepresentativeOct 17
(688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Progress of the Imposition of Other Risk Warning on the Company's SharesSep 30
Announcement on Receipt of the Notice of Response to Retrial and Progress of LitigationSep 15
Semi-annual Report for 2026Aug 22
Announcement on Resignation of Independent DirectorAug 13

All CABIO Biotech (Wuhan) news releases

Follow CABIO Biotech (Wuhan) into a list and get an email when it puts out news.

Follow CABIO Biotech (Wuhan)